Related Experiment Video
Updated: Apr 19, 2026
08:35
A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs
Published on: July 20, 2017
13.8K
ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT
Kate Marie Lewis1, Claudia Petritsch2
1Department of Neurological Surgery, University of California San Francisco, San Francisco 94158, CA, USA.
Translational Neuroscience
|December 23, 2014
Summary
Glioma tumors may arise from neural stem cells. Cell division mode influences glioma type and treatment resistance, suggesting therapeutic targets for prevention and improved outcomes.
Area of Science:
- Neuro-oncology
- Stem Cell Biology
- Cancer Biology
Background:
- Glioma heterogeneity impacts treatment response.
- Brain tumor stem cells and adult neuro-gliogenesis challenge traditional tumor origin theories.
- Neural stem/progenitor cells divide asymmetrically, balancing self-renewal and differentiation.
Purpose of the Study:
- To explore the role of cell division mode in glioma development.
- To investigate how cell division affects tumor type and treatment resistance.
- To identify potential therapeutic targets related to cell division control.
Main Methods:
- Review of existing literature on glioma pathogenesis.
- Analysis of cell division mechanisms in neural stem cells and glioma cells.
- Synthesis of evidence linking cell division mode to tumor formation and therapy response.
Main Results:
- Increased symmetrical cell division in oligodendrocyte progenitor cells correlates with oligodendroglioma formation.
- Asymmetric cell division in astrocytoma stem-like cells may contribute to treatment resistance.
- Cell division mode in normal stem/progenitor cells may dictate tumorigenic potential and glioma type.
Conclusions:
- Cell division mode is a critical factor in glioma initiation and progression.
- Targeting cell division controllers could offer novel therapeutic strategies for glioma.
- Understanding cell division heterogeneity is key to overcoming treatment resistance in glioma.
